Company
Headquarters: New York, NY, United States
CEO: Mr. Eli Decatur Casdin
$389.8 Million
USD as of Sept. 1, 2021
| Company | Market Cap (USD) |
|---|---|
| Berkshire Hathaway | $887.16 B |
| JPMorgan | $599.29 B |
| Visa | $550.38 B |
| Mastercard | $416.63 B |
| Bank of America | $316.02 B |
As of July 22, 2021, CM Life Sciences II Inc. was acquired by SomaLogic, Inc., in a reverse merger transaction. CM Life Sciences II Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
CM Life Sciences II, Inc. has the following listings and related stock indices.
Stock: NASDAQ: CMII wb_incandescent